Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Twist Bioscience Corporation (TWST)

Author's Avatar
Dec 14, 2022

The Class: Robbins+LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Twist Bioscience Corporation (NASDAQ: TWST) common stock between December 13, 2019 and November 14, 2022, for violations of the Securities Exchange Act of 1934. Twist is a biotechnology company that manufactures synthetic DNA and DNA products.